Search results for "HBc"

showing 10 items of 44 documents

Association of hepatitis Be antigen (HBeAg) with the core of the hepatitis B virus (HBcAg).

2008

— Three substances (pronase E, sodium dodecylsulfate (SDS) and guanidine hydrochloride) with different chemical actions partially convert HBcAg to HBeAg. This process retains the integrity of the HBcAg particle, which was not different between HBcAg subpopulations, and does not generate HBcAg or HBeAg sub-units. DNA polymerase activity was destroyed by SDS and guanidine hydrochloride, but not by pronase E. Serum HBeAg could not be converted into HBcAg, suggesting that this might be an irreversible process. The data are consistent with the assumption that HBcAg and HBeAg are coded for by the same gene (C gene of the HBV-DNA).

DNA polymerasePronaseDNA-Directed DNA Polymerasemedicine.disease_causeGuanidinesHepatitis B Antigenschemistry.chemical_compoundAntigenmedicineHumansHepatitis B e AntigensGuanidineGuanidineHepatitisHepatitis B virusHepatologybiologyChemistryvirus diseasesSodium Dodecyl Sulfatemedicine.diseaseHepatitis BVirologyHepatitis B Core Antigensdigestive system diseasesHBcAgHBeAgPronasebiology.proteinLiver
researchProduct

Demonstration and partial characterization of an intermediate HBcAG (Dane particle) population.

1981

Abstract Hepatitis-B core antigen (HBcAg) was released from Dane particles previously separated from anti-HBc by repeated pelleting through sucrose gradients separated into three HBcAg populations when analysed by cesium chloride density gradient centrifugation. Heavy HBcAg particles banded at a density of 1.355 gm/ml, intermediate HBcAg particles at a density of 1.33 gm/ml, and light mediate HBcAg particles at a density of 1.30 gm/ml. Like heavy HBcAg particles, intermediate HBcAg particles contained DNA polymerase activity, but the ratio of HBcAg to DNA polymerase activity was significantly different in both populations. Intermediate HBcAg particles could not be separated from heavy HBcAg…

Differential centrifugationeducation.field_of_studyHepatitis B virusbiologyDNA polymeraseChemistryDane ParticlePopulationvirus diseasesCesiumDNA-Directed DNA PolymeraseVirologyHepatitis B Core Antigensdigestive system diseasesHBcAgInfectious DiseasesChloridesVirologyDNA Viralbiology.proteinCentrifugation Density GradientParticleHumansCentrifugationeducationJournal of medical virology
researchProduct

Detection of Hepatitis B Virus DNA in the Liver of Children with Chronic Hepatitis B by In Situ Hybridization and Its Relation to Other Viral Markers

1992

The aim of the study was to detect hepatitis B virus (HBV) DNA by in situ hybridization (ISH) with a 35S-labeled radioactive probe in frozen liver biopsy tissue sections of 63 hepatitis B virus surface antigen (HBsAg)-positive children. The results were compared to other markers of viral replication. HBV DNA was detected in 48 children. Of the 15 negative cases, four had hepatitis B envelope antigen (HBeAg), 10 anti-HBe, and one neither HBeAg nor anti-HBe. Free HBV DNA in serum and liver was positive in one patient. Forty of the positive children were HBeAg- and six anti-HBe-positive; two were negative for both. Of 45 36 had HBV DNA in serum. In 38 of 47 HBV DNA and in 31 of 42 HBcAg could …

Genetic MarkersMaleHepatitis B virusHBsAgAdolescentHepatitis B virus DNA polymerasemedicine.disease_causemedicineHumansChildHepatitis B virusbiologymedicine.diagnostic_testGastroenterologyInfantNucleic Acid Hybridizationvirus diseasesHepatitis BHepatitis Bbiology.organism_classificationmedicine.diseaseHepatitis B Core AntigensVirologydigestive system diseasesBlotting SouthernHBcAgLiverHepadnaviridaeHBeAgChild PreschoolLiver biopsyChronic DiseaseDNA ViralPediatrics Perinatology and Child HealthFemaleJournal of Pediatric Gastroenterology and Nutrition
researchProduct

Hepatīta B serdes antigēna vīrusveidīgajās daļiņās spontāni iepakoto RNS noteikšana un raksturošana dažādu E. coli producentu celmos

2018

Šajā darbā tika analizētas E. coli producētu HBcAg VVD iepakotās RNS atkarībā no izvēlētās HBcAg ekspresijas plazmīdas un to monomēru vai dimēru formas, izvēlētājiem E. coli celmiem un kultivēšanas barotnes. Pavisam tika analizētas 12 dažādas šo parametru kombinācijas. Tika apskatīti gan kultūru augšanas parametri (kultūru optiskais blīvums un īpatnējā HBcAg produkcija), gan arī analizēta VVD pakotā RNS pēc tās fragmentu garuma un kvalitatīvā sastāva. Trim eksperimenta variantiem arī tika veikta NGS datu analīze. Eksperimenta rezultāti parāda, ka visiem 12 eksperimenta variantiem kvantitatīvi un kvalitatīvi atšķirās VVD iepakotā RNS, bet, lai iegūtu pilnīgāku priekštatu par pakošanas atšķir…

HBcAgpakošanaNGSRNSBioloģijavīrusveidīgās daļiņas
researchProduct

Relationship of pre-S encoded antigens in liver and clinical manifestations of chronic hepatitis B infection.

2008

Pre-S1 and pre-S2 encoded antigens of hepatitis B virus were localized in liver tissue using monoclonal antibodies. They were found to be exclusively expressed in the cytoplasm of liver cells. Cell bound pre-S1 encoded protein was often detected in patients with chronic liver disease and viremia. Only a small number of the HBsAg positive cells also contained pre-S1 antigen. There was no correlation with nuclear HBcAg. Livers of non-viremic HBsAg carriers contained many HBsAg expressing liver cells, that were frequently also positive for pre-S2 encoded protein but contained no detectable pre-S1 encoded protein at all. It remains open whether cell bound pre-S2 containing proteins of middle si…

HBsAgHepatitis B virusBiopsyRadioimmunoassayViremiaBiologyChronic liver diseaseImmunoenzyme Techniques03 medical and health sciencesLiver disease0302 clinical medicineAntigenmedicineHumans030304 developmental biologyHepatitis0303 health sciencesHepatitis B Surface AntigensHepatologyvirus diseasesmedicine.diseasebiology.organism_classificationHepatitis BVirology3. Good healthHBcAgHepadnaviridaeLiverImmunologyCarrier State030211 gastroenterology & hepatologyLiver
researchProduct

HBV-specific immune defect in chronic hepatitis B (CHB) is correlated with a dysregulation of pro- and anti-inflammatory cytokines.

1999

SUMMARY The aim of this study was to examine the immunomodulating effects of rhIL-12 on the immune response induced by hepatitis B virus (HBV) antigens in clinical subgroups of patients with HBV infection. Peripheral blood mononuclear cells (PBMC) of 80 patients were stimulated with HBsAg, HBcAg, pre-S1Ag and tetanus toxoid in the absence or presence of IL-12 (0.01, 0.1 and 1 ng/ml). Stimulation by anti-CD3 + anti-CD28 and lipopolysaccharide (LPS) were used as controls. Proliferation and cytokine production were determined by 3H-thymidine uptake and ELISA after 72 h. After stimulation with HBV antigens only, production of tumour necrosis factor-alpha (TNF-α) or IL-10 was observed in all pat…

HBsAgHepatitis B virusImmunologyAntigen-Presenting CellsIn Vitro Techniquesmedicine.disease_causeLymphocyte ActivationHepatitis B AntigensInterferon-gammaHepatitis B ChronicOrthohepadnavirusmedicineImmunology and AllergyHumansHepatitis B AntibodiesHepatitisHepatitis B virusbiologybusiness.industryTumor Necrosis Factor-alphavirus diseasesOriginal ArticlesHepatitis Bmedicine.diseasebiology.organism_classificationVirologyInterleukin-12digestive system diseasesRecombinant ProteinsInterleukin-10HBcAgHBeAgHepadnaviridaeImmunologyDNA ViralLeukocytes MononuclearCytokinesInflammation MediatorsbusinessClinical and experimental immunology
researchProduct

Immunohistochemical Characterization of 130 Cases of Primary Hepatic Carcinomas

1987

Primary liver carcinoma (PLC) may express a certain number of markers. Here we communicate results of an analysis of five such markers (alpha-1-antitrypsin--AAT--, carcino-embryonic antigen --CEA--, alpha-fetoprotein --AFP--, and superficial --HBsAg-- and core --HBcAg-- antigens of hepatitis B virus) by means of PAP techniques in 130 cases of PLC, comparing the neoplastic tissue and the non-tumorous liver. Three variants of PLC are distinguished: hepatocarcinoma (HC) (108 cases); cholangiocarcinoma (CC) (19 cases); and three cases of hepatocholangiocarcinoma (HCC). AAT was positive in 29 HC, 2 HCC, and negative in all 19 CC. CEA appeared positive in 16 HC, 16 CC and only one HCC. AFP was po…

HBsAgPathologymedicine.medical_specialtyCarcinoma HepatocellularCirrhosismedicine.disease_causePathology and Forensic MedicineImmunoenzyme TechniquesAdenoma Bile DuctAntigenCarcinomamedicineHumansneoplasmsTumor markerHepatitis B virusHepatitis B Surface Antigensbusiness.industryLiver NeoplasmsCell Biologymedicine.diseaseHepatitis B Core AntigensImmunohistochemistrydigestive system diseasesCarcinoembryonic AntigenHBcAgalpha 1-AntitrypsinImmunohistochemistryalpha-FetoproteinsbusinessPathology - Research and Practice
researchProduct

The diagnostic significance of intrahepatocellular hepatitis-B-surface-antigen (HB s Ag), hepatitis-B-core-antigen (HB c Ag) and IgG for the classifi…

1975

Liver biopsies of patients with inflammatory liver diseases and clinically healthy HBsAg-carriers were examined for presence of intracellular HBsAg, HBcAg and IgG by direct immunofluorescence. The studies revealed the following results: 1. In most cases healthy HBsAg-carriers had HBsAg in the cytoplasm, but they did never show HBcAg in the nuclei of hepatocytes. 2. In the early phase some patients with HBsAg-positive acute hepatitis had HBcAg and/or HBsAg in their hepatocytes. In a normal course with complete recovery the immunoelimination may clear either phenomenon at variable stages of the disease. 3. Cases one year after complete recovery of acute virus B-hepatitis had no HB-components …

HBsAgVirusHepatitis B AntigensAntigenDrug DiscoverymedicineHumansDirect fluorescent antibodyGenetics (clinical)Cell NucleusHepatitismedicine.diagnostic_testbusiness.industryLiver cellvirus diseasesGeneral MedicineHepatitis Amedicine.diseasedigestive system diseasesHBcAgLiverVirus DiseasesImmunoglobulin GLiver biopsyAcute DiseaseCarrier StateChronic DiseaseImmunologyMolecular MedicinebusinessKlinische Wochenschrift
researchProduct

IgM-Antikörper gegen Hepatitis B core-Antigen (anti-HBc IgM) bei “gesunden” HBsAg-Trägern. Eine Verlaufsstudie bei 75 Fällen

1981

In 75 healthy HBsAg carriers with normal liver tissue who were followed over a four years period, anti-HBc IgM was determined by ELISA. 61 HBsAg carriers (81%) were positive for anti-HBc IgM at first investigation. 54 individuals demonstrated persistence of anti-HBc IgM, 7 became anti-HBc IgM-negative within the observation period. 12 persons were persistent anti-HBc IgM-negative, and 2 developed anti-HBc IgM of low quantities. 3 of 4 individuals with HBsAg clearance demonstrated a considerable decrease of anti-HBc IgM concentration. Although signs of liver damage or development of chronic liver diseases were not observed at the time of control biopsy the existence of anti-HBcIgM indicates …

HBsAgmedicine.diagnostic_testbiologybusiness.industryvirusesvirus diseasesRadioimmunoassayGeneral MedicineHepatitis Bmedicine.diseaseVirologydigestive system diseasesVirusHBcAgAntigenImmunoglobulin Mparasitic diseasesDrug DiscoveryBiopsyImmunologymedicinebiology.proteinMolecular MedicinebusinessGenetics (clinical)Klinische Wochenschrift
researchProduct

Analysis of the precore DNA sequence and detection of precore antigen in liver specimens from patients with anti-hepatitis b e—positive chronic hepat…

1995

A number of naturally occurring hepatitis B virus (HBV) mutants unable to synthesize the hepatitis B e antigen (HBeAg) have been identified in patients characterized by HBV DNA and anti-HBe in their serum. Because the analysis of the HBV-associated DNA and antigens in the liver tissue is still not complete, we investigated the precore sequence of HBV DNA and its encoded proteins in the liver tissue of 32 patients positive for HBV DNA and anti-HBe in their serum. Three different groups of patients were identified. Group I (n = 14) was characterized by viral DNA sequences with a G-A transition in the distal precore gene region, thus creating a termination codon (TAG). Liver tissue from this g…

Hepatitis B virus0303 health sciencesHBsAgHepatologyvirus diseasesHepatitis BBiologymedicine.disease_causemedicine.diseaseVirologyMolecular biologydigestive system diseasesVirus3. Good healthlaw.invention03 medical and health sciencesHBcAg0302 clinical medicineHBeAglawmedicine030211 gastroenterology & hepatologyViral hepatitisPolymerase chain reaction030304 developmental biologyHepatology
researchProduct